CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Option exercise Director acquired 17,000 shares (option exercise)
- 4 Grant or award Director acquired 15,917 shares (grant or award)
- 4 Grant or award Director acquired 10,861 shares (grant or award)
- 4 Grant or award Director acquired 9,925 shares (grant or award)
- 4 Grant or award Director acquired 10,393 shares (grant or award)
- 4 Grant or award Director acquired 5,290 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
Page 5 of 22 · 427 filings